Xiang Yi
Xiang Yi
確認したメール アドレス: unc.edu
タイトル
引用先
引用先
Novel nanomaterials for clinical neuroscience
JL Gilmore, X Yi, L Quan, AV Kabanov
Journal of NeuroImmune Pharmacology 3 (2), 83-94, 2008
1942008
Synthesis and biological evaluation of substituted 2-sulfonyl-phenyl-3-phenyl-indoles: a new series of selective COX-2 inhibitors
W Hu, Z Guo, F Chu, A Bai, X Yi, G Cheng, J Li
Bioorganic & medicinal chemistry 11 (7), 1153-1160, 2003
1152003
Neuronal uptake and intracellular superoxide scavenging of a fullerene (C60)-poly (2-oxazoline) s nanoformulation
J Tong, MC Zimmerman, S Li, X Yi, R Luxenhofer, R Jordan, AV Kabanov
Biomaterials 32 (14), 3654-3665, 2011
1002011
Agile delivery of protein therapeutics to CNS
X Yi, DS Manickam, A Brynskikh, AV Kabanov
Journal of Controlled Release 190, 637-663, 2014
832014
Transport across the blood-brain barrier of pluronic leptin
TO Price, SA Farr, X Yi, S Vinogradov, E Batrakova, WA Banks, ...
Journal of Pharmacology and Experimental Therapeutics 333 (1), 253-263, 2010
822010
Protein modification with amphiphilic block copoly (2-oxazoline) s as a new platform for enhanced cellular delivery
J Tong, R Luxenhofer, X Yi, R Jordan, AV Kabanov
Molecular pharmaceutics 7 (4), 984-992, 2010
732010
Conjugates of superoxide dismutase 1 with amphiphilic poly (2-oxazoline) block copolymers for enhanced brain delivery: synthesis, characterization and evaluation in vitro and …
J Tong, X Yi, R Luxenhofer, WA Banks, R Jordan, MC Zimmerman, ...
Molecular pharmaceutics 10 (1), 360-377, 2013
632013
Nano-particle delivery of brain derived neurotrophic factor after focal cerebral ischemia reduces tissue injury and enhances behavioral recovery
NM Harris, R Ritzel, NS Mancini, Y Jiang, X Yi, DS Manickam, WA Banks, ...
Pharmacology Biochemistry and Behavior 150, 48-56, 2016
592016
Discovery of 2-Phenyl-3-sulfonylphenyl-indole derivatives as a new class of selective COX-2 inhibitors
W Hu, Z Guo, X Yi, C Guo, F Chu, G Cheng
Bioorganic & medicinal chemistry 11 (24), 5539-5544, 2003
562003
Pluronic-modified superoxide dismutase 1 attenuates angiotensin II-induced increase in intracellular superoxide in neurons
X Yi, MC Zimmerman, R Yang, J Tong, S Vinogradov, AV Kabanov
Free Radical Biology and Medicine 49 (4), 548-558, 2010
552010
Protein conjugation with amphiphilic block copolymers for enhanced cellular delivery
X Yi, E Batrakova, WA Banks, S Vinogradov, AV Kabanov
Bioconjugate chemistry 19 (5), 1071-1077, 2008
492008
Intranasal administration as a route for drug delivery to the brain: evidence for a unique pathway for albumin
JA Falcone, TS Salameh, X Yi, BJ Cordy, WG Mortell, AV Kabanov, ...
Journal of Pharmacology and Experimental Therapeutics 351 (1), 54-60, 2014
462014
Small-sized mPEG–PLGA nanoparticles of Schisantherin A with sustained release for enhanced brain uptake and anti-parkinsonian activity
T Chen, C Li, Y Li, X Yi, R Wang, SMY Lee, Y Zheng
ACS applied materials & interfaces 9 (11), 9516-9527, 2017
412017
Study on molecular mechanism and 3D-QSAR of influenza neuraminidase inhibitors
X Yi, Z Guo, FM Chu
Bioorganic & medicinal chemistry 11 (7), 1465-1474, 2003
412003
Pluronic modified leptin with increased systemic circulation, brain uptake and efficacy for treatment of obesity
X Yi, D Yuan, SA Farr, WA Banks, CD Poon, AV Kabanov
Journal of Controlled Release 191, 34-46, 2014
352014
Principles of strategic drug delivery to the brain (SDDB): development of anorectic and orexigenic analogs of leptin
WA Banks, A Gertler, G Solomon, L Niv-Spector, M Shpilman, X Yi, ...
Physiology & behavior 105 (1), 145-149, 2011
312011
Zebrafish: A promising in vivo model for assessing the delivery of natural products, fluorescence dyes and drugs across the blood-brain barrier
Y Li, T Chen, X Miao, X Yi, X Wang, H Zhao, SMY Lee, Y Zheng
Pharmacological research 125, 246-257, 2017
292017
Nanoformulation of Brain‐Derived Neurotrophic Factor with Target Receptor‐Triggered‐Release in the Central Nervous System
Y Jiang, JM Fay, CD Poon, N Vinod, Y Zhao, K Bullock, S Qin, ...
Advanced functional materials 28 (6), 1703982, 2018
272018
Oral delivery of a nanocrystal formulation of schisantherin a with improved bioavailability and brain delivery for the treatment of Parkinson’s disease
T Chen, C Li, Y Li, X Yi, SMY Lee, Y Zheng
Molecular pharmaceutics 13 (11), 3864-3875, 2016
272016
Brain delivery of proteins via their fatty acid and block copolymer modifications
X Yi, AV Kabanov
Journal of drug targeting 21 (10), 940-955, 2013
242013
現在システムで処理を実行できません。しばらくしてからもう一度お試しください。
論文 1–20